OneMedNet Corp — Director's Dealing 2025

Nov 27, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OneMedNet Corp (ONMD)
CIK: 0001849380
Period of Report: 2025-06-17

Reporting Person: Yu Jeffrey (Director, Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-06-17	Common Stock	C	479270	$1.14	Acquired	3242465	Direct
2025-06-19	Common Stock	C	1828279	$0.71	Acquired	5070744	Direct
2025-06-20	Common Stock	P	1666666	$0.42	Acquired	6737410	Direct
2025-08-19	Common Stock	P	16500	$0.77	Acquired	6753910	Direct
2025-08-21	Common Stock	P	15000	$0.77	Acquired	6768910	Direct
2025-08-25	Common Stock	P	13300	$0.75	Acquired	6782210	Direct
2025-08-26	Common Stock	P	173350	$0.69	Acquired	6955560	Direct
2025-08-27	Common Stock	P	21374	$0.69	Acquired	6976934	Direct
2025-08-28	Common Stock	P	17000	$0.80	Acquired	6993934	Direct
2025-08-29	Common Stock	P	10890	$0.82	Acquired	7004824	Direct
2025-09-02	Common Stock	P	24319	$0.85	Acquired	7029143	Direct
2025-09-03	Common Stock	P	11670	$0.81	Acquired	7040813	Direct
2025-09-04	Common Stock	P	11810	$0.87	Acquired	7052623	Direct
2025-09-05	Common Stock	P	2100	$0.86	Acquired	7054723	Direct
2025-09-18	Common Stock	P	700	$0.91	Acquired	7055423	Direct
2025-09-19	Common Stock	P	1250	$0.89	Acquired	7056673	Direct
2025-09-22	Common Stock	P	400	$0.95	Acquired	7057073	Direct
2025-09-23	Common Stock	P	5700	$0.93	Acquired	7062773	Direct
2025-09-24	Common Stock	P	17200	$1.02	Acquired	7079973	Direct
2025-09-25	Common Stock	P	1250	$1.03	Acquired	7081223	Direct
2025-11-24	Common Stock	A	200000	$0.00	Acquired	7281223	Direct
2025-11-26	Common Stock	A	45000	$0.00	Acquired	7326223	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-06-17	Senior Secured Convertible Note	$1.14	C	479270	Disposed		Common Stock (479270)	Direct
2025-05-09	Warrants (Right to Buy	$11.5	P	5946	Acquired	2028-11-07	Common Stock (5946)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1311970	Indirect

Footnotes

F1: On June 28, 2023, Data Knights Acquisition Corp. ("Data Knights") (the predecessor of the issuer) and certain investors, including the reporting person (collectively, the "Purchasers"), entered into a securities purchase agreement pursuant to which Data Knights issued and sold to the Purchasers senior secured convertible notes (the "PIPE Notes"), which are convertible into shares of common stock at each Purchasers' election, at a conversion price equal to the lower of (i) $10.00 per share, or (ii) 92.5% of the lowest volume weighted average trading price for the ten (10) trading days immediately preceding the conversion date, subject to a floor price of $1.14. The PIPE Notes matured on the first anniversary of the issuance date (November 7, 2024), subject to extension pursuant to the terms of the PIPE Notes. The conversion shares included accrued interest from the date of issuance.

F2: On June 19, 2025, the issuer entered into an agreement with the reporting person to convert an aggregate of approximately $1.3 million of outstanding principal and accrued interest under certain shareholder loans and business combination extension loans.

F3: On June 20, 2025, the issuer entered into a subscription agreement with the reporting person, pursuant which the issuer agreed to sell 1,666,666 shares of common stock to the reporting person at a purchase price of $0.42 per share, totaling $700,000 in gross proceeds to the issuer.

F4: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.76 to $0.79, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in the footnotes of this report.

F5: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.74 to $0.75, inclusive.

F6: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.66 to $0.79, inclusive.

F7: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.68 to $0.72, inclusive.

F8: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.78 to $0.81, inclusive.

F9: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.79 to $0.85, inclusive.

F10: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.83 to $0.88, inclusive.

F11: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.77 to $0.86, inclusive.

F12: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.84 to $0.92, inclusive.

F13: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.84 to $0.90, inclusive.

F14: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.89 to $0.94, inclusive.

F15: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.88 to $0.92, inclusive.

F16: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.93 to $0.99, inclusive.

F17: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.91 to $0.96, inclusive.

F18: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.01 to $1.05, inclusive.

F19: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.03 to $1.04, inclusive.

F20: Represents restricted stock units ("RSUs") granted under the OneMedNet Corporation 2022 Equity Incentive Plan (the "2022 Plan") as employment compensation. RSUs vest as to one-third (1/3) of the RSUs on the first anniversary of the vesting start date of January 1, 2025, with the remaining RSUs vesting thereafter in equal quarterly installments on the last day of each fiscal quarter over the subsequent two (2) years, provided that the recipient remains in continuous service through each vesting date.

F21: Represents RSUs granted as director compensation under the 2022 Plan for board service in fiscal year 2025. The RSUs vest on December 31, 2025, subject to the reporting person's continued service with the issuer through the vesting date.

F22: The shares are held by trust with an independent trustee, in which the reporting person has no investment control. The reporting person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the shares for purposes of Section 16 or for any other purpose.